Search research articles
Contact Us
Filters
Showing results (301-310 of 415) with videos related to
Page
of 42
Sort By:
Chemosphere
|
July 2, 2010
Aerobic biodegradation of [14C] 6:2 fluorotelomer alcohol in a flow-through soil incubation system
Jinxia Liu, Ning Wang, Robert C Buck, et al.
Toxicology
|
December 14, 2011
Toxicological assessment of tridecafluorohexylethyl methacrylate (6:2 FTMAC)
Sathanandam S Anand, Tessa L Serex, Carol Carpenter, et al.
Cell
|
July 18, 1986
Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin
J W Tamkun, D W DeSimone, D Fonda, et al.
Chemosphere
|
November 30, 2010
6:2 fluorotelomer sulfonate aerobic biotransformation in activated sludge of waste water treatment plants
Ning Wang, Jinxia Liu, Robert C Buck, et al.
Archives of Neurology
|
April 1, 1996
Lipids and stroke: a paradox resolved
V Hachinski, C Graffagnino, M Beaudry, et al.
Chemico-Biological Interactions
|
June 6, 2009
Kinetics of 8-2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats
William J Fasano, Lisa M Sweeney, Michael P Mawn, et al.
British Journal of Urology
|
May 1, 1987
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630
C J Beacock, A C Buck, R Zwinck, et al.
Molecular Ecology
|
March 31, 2026
Applying Both Landscape Genomic and Ecological Niche Model Predictions to Inform Conservation Strategies of a California Foundational Oak Species
Ryan C Buck, H Scott Butterfield, Elizabeth H T Hiroyasu, et al.
Chemosphere
|
July 11, 2017
Effects of hydrated lime on radionuclides stabilization of Hanford tank residual waste
Guohui Wang, Wooyong Um, Kirk J Cantrell, et al.
The Journal of Endocrinology
|
November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)
K J Walker, A O Turkes, A Turkes, et al.
Page
of 42
Search research articles
Search
Showing results (301-310 of 415) with videos related to
Sort By:
Page
of 42
Chemosphere
|
July 2, 2010
Aerobic biodegradation of [14C] 6:2 fluorotelomer alcohol in a flow-through soil incubation system
Jinxia Liu, Ning Wang, Robert C Buck, et al.
Toxicology
|
December 14, 2011
Toxicological assessment of tridecafluorohexylethyl methacrylate (6:2 FTMAC)
Sathanandam S Anand, Tessa L Serex, Carol Carpenter, et al.
Cell
|
July 18, 1986
Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin
J W Tamkun, D W DeSimone, D Fonda, et al.
Chemosphere
|
November 30, 2010
6:2 fluorotelomer sulfonate aerobic biotransformation in activated sludge of waste water treatment plants
Ning Wang, Jinxia Liu, Robert C Buck, et al.
Archives of Neurology
|
April 1, 1996
Lipids and stroke: a paradox resolved
V Hachinski, C Graffagnino, M Beaudry, et al.
Chemico-Biological Interactions
|
June 6, 2009
Kinetics of 8-2 fluorotelomer alcohol and its metabolites, and liver glutathione status following daily oral dosing for 45 days in male and female rats
William J Fasano, Lisa M Sweeney, Michael P Mawn, et al.
British Journal of Urology
|
May 1, 1987
The treatment of metastatic prostatic cancer with the slow release LH-RH analogue Zoladex ICI 118630
C J Beacock, A C Buck, R Zwinck, et al.
Molecular Ecology
|
March 31, 2026
Applying Both Landscape Genomic and Ecological Niche Model Predictions to Inform Conservation Strategies of a California Foundational Oak Species
Ryan C Buck, H Scott Butterfield, Elizabeth H T Hiroyasu, et al.
Chemosphere
|
July 11, 2017
Effects of hydrated lime on radionuclides stabilization of Hanford tank residual waste
Guohui Wang, Wooyong Um, Kirk J Cantrell, et al.
The Journal of Endocrinology
|
November 1, 1984
Treatment of patients with advanced cancer of the prostate using a slow-release (depot) formulation of the LHRH agonist ICI 118630 (Zoladex)
K J Walker, A O Turkes, A Turkes, et al.
Page
of 42